 |
Journal articles
Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis
Abstract : Glioblastoma is one of the most lethal forms of adult cancer with a median survival of around 15 months. A potential treatment strategy involves targeting glioblastoma stem-like cells (GSC), which constitute a cell autonomous reservoir of aberrant cells able to initiate, maintain, and repopulate the tumor mass. Here, we report that the expression of the paracaspase mucosa-associated lymphoid tissue l (MALT1), a protease previously linked to antigen receptor-mediated NF-jB activation and B-cell lymphoma survival, inversely correlates with patient probability of survival. The knockdown of MALT1 largely impaired the expansion of patient-derived stem-like cells in vitro, and this could be recapitulated with pharmacological inhibitors, in vitro and in vivo. Blocking MALT1 protease activity increases the endo-lysosome abundance, impairs autophagic flux, and culminates in lysosomal-mediated cell death, concomitantly with mTOR inactiva-tion and dispersion from endo-lysosomes. These findings place MALT1 as a new druggable target involved in glioblastoma and unveil ways to modulate the homeostasis of endo-lysosomes.
Cited literature [82 references]
https://www.hal.inserm.fr/inserm-02395350
Contributor : Elizabeth Bernardo <>
Submitted on : Thursday, December 5, 2019 - 2:11:23 PM
Last modification on : Monday, May 25, 2020 - 8:30:03 PM
Document(s) archivé(s) le : Friday, March 6, 2020 - 3:11:11 PM
Contributor : Elizabeth Bernardo <>
Submitted on : Thursday, December 5, 2019 - 2:11:23 PM
Last modification on : Monday, May 25, 2020 - 8:30:03 PM
Document(s) archivé(s) le : Friday, March 6, 2020 - 3:11:11 PM
